Navigation Links
Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration With Oxygen Healthcare (O2h)
Date:5/25/2010

i(s_account);s.linkTrackVars='prop5,eVar3,prop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='94836224';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.o2h.com">http://www.o2h.com.

About Heptares Therapeutics

Heptares is a drug discovery company focused on identifying novel drug candidates targeting validated G-protein-coupled receptors (GPCRs) in several disease areas. Based on its unique StaR(TM) technology platform, Heptares has built an integrated drug discovery capability and aims to progress promising candidates internally and through strategic alliances.

GPCRs are the single most important family of drug targets in the human body, but because of their inherent instability they are refractory to structural studies and biochemical screening. StaR technology enables the engineering of stabilised GPCRs, making them amenable to these vital drug discovery approaches. There are many clinically relevant GPCR targets across a wide range of therapeutic areas where discovery is advancing slowly and for which structural information, novel screening approaches and potential antibody therapeutics would greatly enhance progress.

Heptares was founded in 2007 and its StaR technology arose out of the pioneering work of Heptares' founding scientists at the MRC Laboratory of Molecular Biology (Cambridge, UK) and the National Institute for Medical Research (London, UK).

    For more information, see http://www.heptares.com

    Contact information:

    Dr. Ekta Ahuja
    
SOURCE O2h
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
2. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
3. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
4. Trius Therapeutics Awarded U.S. Department of Defense Contract to Develop Novel Antibiotics
5. Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics
6. Fate Therapeutics Expands Scientific Advisory Board to Advance iPSC Technology and Stem Cell Modulator Pipeline
7. Nile Therapeutics Announces Exercise of Over-Allotment Option for Recent Public Offering
8. Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
9. Orexigen(R) Therapeutics to Speak at Ninth Annual JMP Securities Research Conference
10. Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study
11. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... In today,s fast changing healthcare environment, ... positive health outcomes, improve profitability and enhance their ... in their communities. At ThoughtSpot 2015, Good ... announced a new set of innovative capabilities that ... help independent pharmacies endure the industry,s most pressing ...
(Date:7/31/2015)... ... July 31, 2015 , ... Global ... and premium industry insights on the global resorcinol industry. The report highlights the ... of vivid market scenarios and analysis of primary and secondary inputs from the ...
(Date:7/31/2015)... 2015 China Cord Blood Corporation (NYSE: CO) ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has filed its Annual Report ... Commission. The filed Form 20-F includes audited financial statements ... Form 20-F can be accessed by visiting the U.S. ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
Breaking Biology Technology:AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
... Biotherapeutics (OTC Bulletin Board: NWBO ) announced today ... a presentation on "Autologous Dendritic Cells for Glioblastoma" on Saturday, ... Meeting of the American Society of Cell and Gene Therapy ... rooms 615-617 at the Washington State Convention Center. ...
... and PARSIPPANY, N.J., May 20, 2011 During a ,Day ... Science Park High School experienced what it was like to ... hosted by Students 2 Science, Inc. (S2S). The "A Day ... many integrated full-year science education programs offered by S2S that ...
... InterMune, Inc. (NASDAQ: ITMN ) will conduct ... on Thursday, May 26, 2011, from 8:30 a.m. – ... executive management team will provide an overview of the ... commercial and scientific plans.  The company also will provide ...
Cached Biology Technology:Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy 2Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy 3Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 2Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 3InterMune to Webcast 2011 Analyst Day Presentations 2
(Date:7/31/2015)... , Kina, 31. juli 2015 Den ... bliver afholdt af BGI fra den 22. - 25. oktober ... Konferencen fejrer sin 10-års fødselsdag i år. Siden ... mest indflydelsesrige årlige møder på ,omik,-feltet, og er en ... ICG-10 fokuserer på nylige gennembrud og ...
(Date:7/31/2015)... 31 de julio de 2015 BGI llevará a ... ) del 22 al 25 de octubre de 2015, ... La conferencia celebra su décimo aniversario este año. Desde ... una de las reuniones anuales más influyentes del mundo ... de las conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... the western Antarctic Peninsula since 1850 The ... over the past 50 years (the period of observational ... on the fringes of the peninsula disintegrating. Despite this, ... of days with snowfall has increased by at least ...
... MD The Biophysical Society has announced the speakers for ... of the Biophysical Society and the International Biophysics Congress ... The new and notable symposium highlights the latest and ... and selected by the Societys program committee. The ...
... is a tiny yet insidious waterborne parasite that wreaks ... diarrhea and malnutrition in small children in developing countries, ... compromised patients in the developed world. Cryptosporidium is resistant ... the U.S., which has led to the concern that ...
Cached Biology News:AGU journal highlights -- Jan. 28, 2008 2AGU journal highlights -- Jan. 28, 2008 3AGU journal highlights -- Jan. 28, 2008 4AGU journal highlights -- Jan. 28, 2008 5AGU journal highlights -- Jan. 28, 2008 6Biophysical Society announces new and notable symposium speakers 2Breakthrough research turns the tide on water-borne pathogen 2
US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
... Primer is designed for sequencing inserts cloned ... V2051, V2061). The primer hybridizes upstream of ... approximately 4050 base pairs upstream of the ... to determine if an insert is cloned ...
Request Info...
...
Biology Products: